title: Classification of antituberculosis drugs: a new proposal based on the most recent evidence.
authors.affiliation: Pneumology Department, University Hospital of Gran Canaria "Dr. Negrin", Las Palmas, Spain MDR-TB Unit, International Union against Tuberculosis and Lung Disease (The Union), Paris, France jcamlun@gobiernodecanarias.org.
authors.forename: Jose A
authors.initials: JA
authors.lastname: Caminero
authors.affiliation: MDR-TB Unit, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.
authors.forename: Anna
authors.initials: A
authors.lastname: Scardigli
mesh_terms: D000995:Antitubercular Agents / Q000145:classification*; D015780:Carbapenems / Q000008:administration & dosage; D019818:Clavulanic Acid / Q000008:administration & dosage; D002991:Clofazimine / Q000008:administration & dosage; D064687:Diarylquinolines / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy*; D006801:Humans; D055552:Infectious Disease Medicine / Q000379:methods / Q000592:standards*; D000069349:Linezolid / Q000008:administration & dosage; D009593:Nitroimidazoles / Q000008:administration & dosage; D010080:Oxazoles / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents; D015780:Carbapenems; D064687:Diarylquinolines; D009593:Nitroimidazoles; C516022:OPC-67683; D010080:Oxazoles; D019818:Clavulanic Acid; C493870:bedaquiline; D002991:Clofazimine; D000069349:Linezolid